Arlington Partners LLC Has $3.19 Million Position in Danaher Co. (NYSE:DHR)

Arlington Partners LLC reduced its holdings in shares of Danaher Co. (NYSE:DHR) by 3.3% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 13,880 shares of the conglomerate’s stock after selling 471 shares during the period. Arlington Partners LLC’s holdings in Danaher were worth $3,186,000 as of its most recent SEC filing.

A number of other large investors have also recently bought and sold shares of DHR. FMR LLC grew its holdings in Danaher by 15.8% during the 3rd quarter. FMR LLC now owns 23,617,424 shares of the conglomerate’s stock worth $6,566,116,000 after acquiring an additional 3,217,631 shares during the period. Massachusetts Financial Services Co. MA grew its stake in shares of Danaher by 17.6% in the 3rd quarter. Massachusetts Financial Services Co. MA now owns 3,582,982 shares of the conglomerate’s stock valued at $996,141,000 after buying an additional 535,254 shares during the period. International Assets Investment Management LLC grew its stake in shares of Danaher by 40,196.5% in the 3rd quarter. International Assets Investment Management LLC now owns 429,964 shares of the conglomerate’s stock valued at $119,539,000 after buying an additional 428,897 shares during the period. Montrusco Bolton Investments Inc. grew its stake in shares of Danaher by 30.4% in the 3rd quarter. Montrusco Bolton Investments Inc. now owns 1,705,884 shares of the conglomerate’s stock valued at $465,617,000 after buying an additional 397,671 shares during the period. Finally, Union Bancaire Privee UBP SA acquired a new stake in shares of Danaher in the 4th quarter valued at about $74,551,000. 79.05% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling

In related news, SVP Brian W. Ellis sold 5,700 shares of Danaher stock in a transaction that occurred on Thursday, January 30th. The shares were sold at an average price of $224.13, for a total value of $1,277,541.00. Following the sale, the senior vice president now owns 20,230 shares of the company’s stock, valued at approximately $4,534,149.90. The trade was a 21.98 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 11.10% of the stock is currently owned by insiders.

Analysts Set New Price Targets

Several brokerages have recently commented on DHR. KeyCorp raised their target price on Danaher from $290.00 to $310.00 and gave the company an “overweight” rating in a research note on Wednesday, October 23rd. Barclays reduced their target price on Danaher from $275.00 to $240.00 and set an “equal weight” rating for the company in a research note on Thursday, January 30th. Stifel Nicolaus raised their target price on Danaher from $250.00 to $265.00 and gave the company a “hold” rating in a research note on Wednesday, October 23rd. Royal Bank of Canada reaffirmed an “outperform” rating and issued a $277.00 price target (down previously from $299.00) on shares of Danaher in a research report on Thursday, January 30th. Finally, StockNews.com cut shares of Danaher from a “buy” rating to a “hold” rating in a research report on Saturday, December 14th. Seven research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $278.00.

Danaher Trading Down 1.5 %

NYSE:DHR opened at $206.92 on Monday. The company has a current ratio of 1.40, a quick ratio of 1.05 and a debt-to-equity ratio of 0.31. The stock has a market capitalization of $149.45 billion, a PE ratio of 39.19, a price-to-earnings-growth ratio of 2.68 and a beta of 0.83. The firm’s 50 day moving average is $232.72 and its 200 day moving average is $251.70. Danaher Co. has a 12 month low of $205.79 and a 12 month high of $281.70.

Danaher (NYSE:DHR) last posted its quarterly earnings results on Wednesday, January 29th. The conglomerate reported $2.14 EPS for the quarter, hitting analysts’ consensus estimates of $2.14. Danaher had a net margin of 16.33% and a return on equity of 10.82%. During the same period in the previous year, the firm posted $2.09 EPS. Sell-side analysts expect that Danaher Co. will post 7.67 earnings per share for the current year.

Danaher Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, January 31st. Investors of record on Friday, December 27th were issued a $0.27 dividend. The ex-dividend date was Friday, December 27th. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.52%. Danaher’s dividend payout ratio (DPR) is presently 20.45%.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.